It markets Keytruda, a cancer drug that topped the list of ... The company will, no doubt, launch other brand-new products. Merck recently signed an agreement to develop a weight loss medicine with ...

Mylan N.V. (MYL +0.5%) announces the U.S. commercial launch of perphenazine tablets, the generic version of Merck (NYSE:MRK)'s ...

Takeda boosts profit margins with AI-driven growth, FY2024 guidance upgrade, share buyback plan & promising drug launches.

KENNEDY SPACE CENTER, Fla. —NASA and SpaceX’s Crew-10 astronauts will arrive at the Kennedy Space Center on Friday, March 7, to prepare for their flight to the International Space Station.

The trial will include patients with locally advanced or metastatic HER2-positive, PD-L1-positive gastric or gastroesophageal junction cancer.